logo

For the Inventor, By the Inventor

Moscow, Russia

Ali S Turgiev

This inventor holds 8 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent. Top assignees: Billings Pharmaceuticals, Inc., Other. Active years: 1999-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ali S Turgiev. Retrieved from https://idiyas.com/inventor/ali-s-turgiev

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 75.0


Average Co-Inventor Count = 3.2

ph-index = 3

Forward Citations = 25(Granted Patents)


Company Filing History:

goldMedal3 out of 3 
 
Billings Pharmaceuticals, Inc.
 patents
silverMedal5 out of 834,513 
Other
 patents

Years Active: 1999-2008

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents
1. 7321002 - Chiral integrin modulators and methods of use thereof (2008-01-22),
2. 7045663 - Chiral integrin modulators and methods of use thereof (2006-05-16),
3. 6177475 - Methods of using integrin modulators for treatment of inflammation (2001-01-23),
4. 5981602 - Methods of using Ajoene for inhibiting integrin-mediated cell-cell fusion (1999-11-09),
5. 5948821 - Methods of using ajoene (1999-09-07),
6. 5863955 - Methods of using ajoene to inhibit an immune response (1999-01-26),
7. 5863954 - Contraceptive method using ajoene (1999-01-26),
8. 5856363 - Methods of using ajoene (1999-01-05),

Title: The Innovative Contributions of Ali S Turgiev

Introduction

Ali S Turgiev is a prominent inventor based in Moscow, Russia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of chiral integrin modulators. With a total of eight patents to his name, Turgiev's work has the potential to impact various medical treatments and improve patient outcomes.

Latest Patents

Among his latest patents is the invention titled "Chiral integrin modulators and methods of use thereof." This invention provides enantiomers of ajoene and derivatives of Z(−)-ajoene. The derivatives of Z(−)-ajoene are particularly useful for modulating integrin-mediated functions. They can be applied in treating disorders, diseases, or conditions where integrins play a crucial role. Additionally, these compounds can enhance the condition of tissues for subsequent uses, such as transplantation.

Career Highlights

Throughout his career, Turgiev has worked with notable companies, including Billings Pharmaceuticals, Inc. His innovative approach and dedication to research have led to advancements in the pharmaceutical industry. His work continues to inspire future developments in medical treatments.

Collaborations

Turgiev has collaborated with esteemed colleagues, including Alexander V Tatarintsev and John B Davidson. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Ali S Turgiev's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work in developing chiral integrin modulators showcases the potential for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…